Published • loading... • Updated
NETPark company Magnitude Biosciences identifies new potential uses for existing medicines
Summary by NETPark North East Technology Park
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
NETPark company Magnitude Biosciences identifies new potential uses for existing medicines
NETPark-based Magnitude Biosciences has published a new case study demonstrating how its technology can help researchers identify potential new therapeutic uses for existing medicines.Whole-organism drug screening using FDA-approved compoundsThe company used its VivoScan platform to screen a focused panel of 180 drugs selected from a library of more than 7,000 FDA-approved compounds. The aim was to identify medicines that produced measurable imp…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
